Partnership provides physicians using the ZappRx prescribing platform with a streamlined way to prescribe respiratory medication and provide access to associated programs
Agreement designed to help patients with pulmonary hypertension and multiple sclerosis access their medications faster
- Strategic agreement brings together two companies committed to the use of digital solutions that seek to improve patient lives.
- The arrangement begins with idiopathic pulmonary fibrosis (IPF) and may continue with allergic asthma and chronic idiopathic urticaria.
BOSTON--(BUSINESS WIRE)--ZappRx announced today that it has entered into an agreement with Genentech. The agreement will start by seeking to improve patient access to specialty drugs in IPF, with an option to continue in allergic asthma, and chronic idiopathic urticaria.
Nonprofit invests in leading specialty prescription and prior authorization solution provider to get Duchenne patients breakthrough medications, faster
Digital health company partners with New Jersey-based specialty pharmacy to speed up prescription access for patients across the U.S.
SOC 2 Type 2 adaptation demonstrates health tech leader’s commitment to compliance and security of protected patient information
Forbes Boston Business Council Is an Invitation-Only Community for Greater Boston Business Owners and Leaders
BOSTON--(BUSINESS WIRE)--ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, is exhibiting at the annual PHA International Conference this weekend from June 29 – July 1, in Orlando, FL. The company will be showcasing its revolutionary technology that digitizes and automates the inefficient specialty prescribing and prior authorization process. Members of the ZappRx team will also be on site to provide attendees with updates on recent, notable customer partnerships and company growth.
Collaboration improves quality of care and empowers healthcare providers across multiple specialties with streamlined, digital prescribing and prior authorization
HITRUST CSF Certification validates ZappRx is committed to meeting key regulations and protecting sensitive information.
Collaboration empowers healthcare providers with easy access to patient drug history and mission critical information about the medications prescribed on the ZappRx platform
BOSTON--(BUSINESS WIRE)--ZappRx, a healthcare technology company that reduces the administrative burden associated with prescribing specialty medications, today announced a collaboration with FDB (First Databank) to embed its electronic prescribing solution, FDB MedsTracker® eRx, directly into its specialty drug prescribing and prior authorization platform. Announced at the Asembia 2018 Specialty Pharmacy Summit in Las Vegas, where ZappRx is exhibiting in booth 818, the integration speeds delivery of specialty drugs to patients and empowers physicians with increased transparency and easy access to key prescribing information.
Boston, MA, November 14, 2017 – ZappRx, a healthcare technology company that reduces the administrative burden associated with prescribing specialty medications, today announced the appointment of Rich Kramer to Vice President of Commercial Operations. Within his new role, Kramer will report directly to Sandy DiCesare, Chief Operating Officer of ZappRx, and will lead ZappRx’s provider sales team as it continues implementing the platform into physician practices, health systems, and clinics across the United States.
Boston, MA, November 14, 2017 – ZappRx, a healthcare technology company that reduces the administrative burden associated with prescribing specialty medications, today announced the appointment of James Cornicelli as Vice President of Corporate Strategy. In his new role, Cornicelli will develop and execute the company’s BioPharma and payer partnering strategy. He will also build and lead a team of business development experts to foster existing partnerships and pursue new partners.
Appoints Libby Curtis Webb to Senior Vice President of Product
The platform will be used by healthcare providers to simplify the complex and time-consuming process of prescribing specialty medications.
ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, announced today that Julia Austin has joined its Board of Directors. Over the past several years, Austin has successfully led large organizations in technical positions, and partnered with entrepreneurs to help start and scale technology companies. As a member of its Board, Austin will provide leadership coaching to ZappRx with a focus on engineering, process, staffing, and functional operations.
ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, today announced that its platform has been deployed at the Division of Pulmonary, Critical Care and Sleep Medicine at Tufts Medical Center, with plans to extend to other areas within the Tufts Medical Center.
Digital health company ZappRx will use the funding to build its team, drive provider adoption nationwide, and accelerate company growth
ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to specialty therapy, announced a partnership with PARx Solutions (parxsolutions.com), a leader in helping prescribers manage prescription prior authorizations (PA). This strategic partnership combines ZappRx’s expertise in automating the specialty drug prescribing process with PARx’s expertise in helping prescribers overcome challenges experienced during prior authorization that lead to delays in patients receiving their medications.
The process of filling a prescription for a specialty drug can be incredibly time consuming and complex, requiring reams of paperwork from healthcare providers. Zoe Barry, a 31-year-old Wall Street veteran, became interested in tackling those inefficiencies after her younger brother was diagnosed with severe epilepsy.
Boston, MA, September 20, 2016 – ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to therapy, today announced the hiring of Sandy DiCesare as Chief Operating Officer. DiCesare most recently served as VP of Commercial Operations at Takeda Oncology. She joined Millennium Pharmaceuticals in 1998 as VP, Information Technology and then served as VP, Launch Platform in 2002, leading the build-out of capabilities to support Millennium's first oncology launch. Millennium Pharmaceutical was acquired by Takeda Pharmaceutical Company Limited in 2008.
Boston, MA, April 27, 2016 – ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing efficient patient access to therapy, today announced the hiring of Lorrie Carr as Chief Commercial Officer. Carr previously served as Divisional VP, Enterprise Specialty Sales & Product Management at Walgreens and has held leadership roles in Global Market Access, Sales and Marketing within pharmaceutical companies Millennium Pharmaceuticals (now Takeda Oncology) and Schering-Plough (now Merck).
Boston, MA, December 14, 2015 – Books are gifts that keep on giving. They inspire lifelong learning, and help improve literacy and language skills. That’s why on Tuesday, December 8, 2015, ZappRx employees partnered with Wonderland BookSavers of Connecticut and Reach Out and Read to donate nearly 2,000 books to Floating Hospital for Children at Tufts Medical Center.
Cambridge, MA, September 9, 2015 – Zoë Barry, Founder and CEO of ZappRx, the leading mobile platform that automates specialty drug prescription management for patients, physicians and pharmacists, has been named to Boston Business Journal’s prestigious 40 under 40 list. This year’s list focuses on business and civic leaders who are making a major impact in the community while also improving the civic health of the Boston area through volunteer work and other forms of philanthropy.
Boston, MA, April 2, 2015 – ZappRx (zapprx.com), today announced that it has raised a $5.6M Series A round led by SR One, the venture arm of GlaxoSmithKline, with participation from Atlas Ventures. ZappRx is building the leading mobile platform to automate specialty drug prescription management for patients, physicians, and pharmacists. The company also announced a partnership with biopharmaceutical company Zafgen (NASDAQ: ZFGN), to help automate the prescription management process for patients affected by Prader-Willi syndrome (PWS) and hypothalamic injury-associated obesity (HIAO). Additionally, Jeremy Levin, former CEO of Teva Pharmaceutical, has also joined the board of ZappRx.
Most specialty medicine needs preauthorization for insurance coverage and it's a headache for providers and staff. ZappRX hopes to solve the problem with a web-based app.
A new podcast series devoted to raising global pulmonary hypertension awareness with dynamic stories from PH patients, caregivers and medical professionals from around the world. In this episode, phaware speaks with Libby Curtis Webb, Senior Vice President, Product of ZappRx, a digital health company offering a specialty prescription and prior authorization platform. Libby discusses how ZappRx is leveraging technology to simplify and automate the way specialty drugs get to patients.
Two years after a family member's diagnosis, Barry founded ZappRx, a company that simplifies the process of ordering and filling specialty medication prescriptions. ZappRx provides a single platform where all the relevant information about a patient and their prescription can be accessed by pharmacists, payers, and medical providers at any time. Barry describes it as “Kayak meets Amazon for $100,000 specialty drugs.”
Prior Authorization (PA) is considered a necessary evil in today’s prescribing process.
ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, today announced that its platform has been deployed at the Division of Pulmonary, Critical Care and Sleep Medicine at Tufts Medical Center
ZappRx and Digital Pharmacist are completely different businesses but they both use digital technology to help their customers navigate the complex process of drug ordering and related services.
ZappRx, a digital health startup that provides a platform to expedite the process of prescribing specialty drugs, announced today that its solution has been deployed at Tufts Medical Center.
Digital specialty prescribing platform ZappRx has raised $25 million in Series B funding in a round led by Qiming US Healthcare Fund. GV, formerly Google Ventures, and SR One also contributed funding.